BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause 2019;26:1071-84. [PMID: 31453973 DOI: 10.1097/GME.0000000000001326] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoshida Y, Chen Z, Baudier RL, Krousel-wood M, Anderson AH, Fonseca VA, Mauvais-jarvis F. Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.01.016] [Reference Citation Analysis]
2 Rahman A, Jackson H, Hristov H, Isaacson RS, Saif N, Shetty T, Etingin O, Henchcliffe C, Brinton RD, Mosconi L. Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks. Front Aging Neurosci 2019;11:315. [PMID: 31803046 DOI: 10.3389/fnagi.2019.00315] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
3 Mehta J, Manson JE. Menopausal hormone therapy and hypertension: minimizing risk. Menopause 2021;28:1201-2. [PMID: 34726660 DOI: 10.1097/GME.0000000000001868] [Reference Citation Analysis]
4 Tjoe B, Fell B, Levee A, Wei J, Shufelt C. Current Perspective on Menopause Hormone Therapy and Cardiovascular Risk. Curr Treat Options Cardio Med 2021;23. [DOI: 10.1007/s11936-021-00917-2] [Reference Citation Analysis]
5 Schelbaum E, Loughlin L, Jett S, Zhang C, Jang G, Malviya N, Hristov H, Pahlajani S, Isaacson R, Dyke JP, Kamel H, Brinton RD, Mosconi L. Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife. Neurology 2021;97:e2328-39. [PMID: 34732544 DOI: 10.1212/WNL.0000000000012941] [Reference Citation Analysis]
6 Kirichenko TV, Myasoedova VA, Ravani AL, Sobenin IA, Orekhova VA, Romanenko EB, Poggio P, Wu WK, Orekhov AN. Carotid Atherosclerosis Progression in Postmenopausal Women Receiving a Mixed Phytoestrogen Regimen: Plausible Parallels with Kronos Early Estrogen Replacement Study. Biology (Basel) 2020;9:E48. [PMID: 32155747 DOI: 10.3390/biology9030048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Fonseca MIH, Almeida-Pititto B, Bittencourt MS, Bensenor IM, Lotufo PA, Ferreira SRG. Menopause Per se Is Associated with Coronary Artery Calcium Score: Results from the ELSA-Brasil. J Womens Health (Larchmt) 2021. [PMID: 34520264 DOI: 10.1089/jwh.2021.0182] [Reference Citation Analysis]
8 Vaura F, Palmu J, Aittokallio J, Kauko A, Niiranen T. Genetic, Molecular, and Cellular Determinants of Sex-Specific Cardiovascular Traits. Circ Res 2022;130:611-31. [PMID: 35175841 DOI: 10.1161/CIRCRESAHA.121.319891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jaff NG, Crowther NJ. The Association of Reproductive Aging with Cognitive Function in Sub-Saharan African Women. Methods Mol Biol 2022;2343:71-91. [PMID: 34473316 DOI: 10.1007/978-1-0716-1558-4_5] [Reference Citation Analysis]
10 Ramesh S, James MT, Holroyd-Leduc JM, Wilton SB, Sola DY, Ahmed SB. Heart rate variability as a function of menopausal status, menstrual cycle phase, and estradiol level. Physiol Rep 2022;10:e15298. [PMID: 35608101 DOI: 10.14814/phy2.15298] [Reference Citation Analysis]
11 Baumgartner NE, Daniel JM. Estrogen receptor α: a critical role in successful female cognitive aging. Climacteric 2021;24:333-9. [PMID: 33522313 DOI: 10.1080/13697137.2021.1875426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kumar A, McCullough L. Cerebrovascular disease in women. Ther Adv Neurol Disord 2021;14:1756286420985237. [PMID: 33552237 DOI: 10.1177/1756286420985237] [Reference Citation Analysis]
13 Lester SP, Vegunta S. Influence of Menopausal Hormone Therapy on the Breast: Counseling Your Patients Before You Prescribe. J Womens Health (Larchmt) 2021. [PMID: 34788572 DOI: 10.1089/jwh.2021.0322] [Reference Citation Analysis]
14 Giordano Imbroll M, Gruppetta M. A current perspective into young female sex hormone replacement: a review. Expert Rev Endocrinol Metab 2020;15:405-14. [PMID: 32893689 DOI: 10.1080/17446651.2020.1816820] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Davis SR, Baber RJ. Treating menopause - MHT and beyond. Nat Rev Endocrinol 2022. [PMID: 35624141 DOI: 10.1038/s41574-022-00685-4] [Reference Citation Analysis]
16 Manwani B, Fall P, Zhu L, O'Reilly MR, Conway S, Staff I, McCullough LD. Increased P450 aromatase levels in post-menopausal women after acute ischemic stroke. Biol Sex Differ 2021;12:8. [PMID: 33413673 DOI: 10.1186/s13293-020-00357-w] [Reference Citation Analysis]
17 El Khoudary SR, Manson JE. Does publication bias explain the divergent findings on menopausal hormone therapy and cardioprotection in the literature? Res Pract Thromb Haemost 2021;5:e12515. [PMID: 33977214 DOI: 10.1002/rth2.12515] [Reference Citation Analysis]
18 Ebenebe OV, Ashley Z, Erickson JR, Heather AK. A Timing Effect of 17-β Estradiol on Atherosclerotic Lesion Development in Female ApoE-/- Mice. Int J Mol Sci 2020;21:E4710. [PMID: 32630298 DOI: 10.3390/ijms21134710] [Reference Citation Analysis]
19 Mosconi L, Berti V, Dyke J, Schelbaum E, Jett S, Loughlin L, Jang G, Rahman A, Hristov H, Pahlajani S, Andrews R, Matthews D, Etingin O, Ganzer C, de Leon M, Isaacson R, Brinton RD. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Sci Rep 2021;11:10867. [PMID: 34108509 DOI: 10.1038/s41598-021-90084-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Niță AR, Knock GA, Heads RJ. Signalling mechanisms in the cardiovascular protective effects of estrogen: With a focus on rapid/membrane signalling. Curr Res Physiol 2021;4:103-18. [PMID: 34746830 DOI: 10.1016/j.crphys.2021.03.003] [Reference Citation Analysis]
21 Barsky L, Shufelt C, Lauzon M, Johnson BD, Berga SL, Braunstein G, Bittner V, Shaw L, Reis S, Handberg E, Pepine CJ, Bairey Merz CN. Prior Oral Contraceptive Use and Longer Term Mortality Outcomes in Women with Suspected Ischemic Heart Disease. J Womens Health (Larchmt) 2021;30:377-84. [PMID: 33481672 DOI: 10.1089/jwh.2020.8743] [Reference Citation Analysis]
22 Hugenschmidt CE, Duran T, Espeland MA. Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment. Climacteric 2021;24:359-65. [PMID: 33586564 DOI: 10.1080/13697137.2021.1877652] [Reference Citation Analysis]
23 Mielke MM, Miller VM. Improving clinical outcomes through attention to sex and hormones in research. Nat Rev Endocrinol 2021. [PMID: 34316045 DOI: 10.1038/s41574-021-00531-z] [Reference Citation Analysis]
24 Vigneswaran K, Hamoda H. Hormone replacement therapy - Current recommendations. Best Pract Res Clin Obstet Gynaecol 2021:S1521-6934(21)00180-2. [PMID: 35000809 DOI: 10.1016/j.bpobgyn.2021.12.001] [Reference Citation Analysis]
25 Jett S, Malviya N, Schelbaum E, Jang G, Jahan E, Clancy K, Hristov H, Pahlajani S, Niotis K, Loeb-zeitlin S, Havryliuk Y, Isaacson R, Brinton RD, Mosconi L. Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention. Front Aging Neurosci 2022;14:831807. [DOI: 10.3389/fnagi.2022.831807] [Reference Citation Analysis]
26 Sickinghe AA, Korporaal SJA, den Ruijter HM, Kessler EL. Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction. Front Endocrinol (Lausanne) 2019;10:442. [PMID: 31333587 DOI: 10.3389/fendo.2019.00442] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
27 Zhu D, Montagne A, Zhao Z. Alzheimer's pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci 2021;78:4907-20. [PMID: 33844047 DOI: 10.1007/s00018-021-03830-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Mulvagh SL, Mullen K, Nerenberg KA, Kirkham AA, Green CR, Dhukai AR, Grewal J, Hardy M, Harvey PJ, Ahmed SB, Hart D, Levinsson AL, Parry M, Foulds HJ, Pacheco C, Dumanski SM, Smith G, Norris CM. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman. CJC Open 2021. [DOI: 10.1016/j.cjco.2021.09.013] [Reference Citation Analysis]
29 Liu JH. The Role of Progestogens in Menopausal Hormone Therapy. Clin Obstet Gynecol 2021;64:772-83. [PMID: 34593694 DOI: 10.1097/GRF.0000000000000657] [Reference Citation Analysis]
30 Smith T, Sahni S, Thacker HL. Postmenopausal Hormone Therapy-Local and Systemic: A Pharmacologic Perspective. J Clin Pharmacol 2020;60 Suppl 2:S74-85. [PMID: 33274517 DOI: 10.1002/jcph.1740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Mühleck F, Laufs U. [Primary prevention of coronary heart disease : Evidence-based drug treatment]. Herz 2020;45:39-49. [PMID: 31822926 DOI: 10.1007/s00059-019-04873-3] [Reference Citation Analysis]
32 Pandurevic S, Macut D, Fanelli F, Pagotto U, Gambineri A. Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk. Biomolecules 2021;11:1350. [PMID: 34572562 DOI: 10.3390/biom11091350] [Reference Citation Analysis]
33 Yoshida Y, Chen Z, Baudier RL, Krousel-Wood M, Anderson AH, Fonseca VA, Mauvais-Jarvis F. Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women. Diabetes Care 2021;44:2564-72. [PMID: 34475032 DOI: 10.2337/dc21-1107] [Reference Citation Analysis]
34 Zhang Y, Ogola BO, Iyer L, Karamyan VT, Thekkumkara T. Estrogen Metabolite 2-Methoxyestradiol Attenuates Blood Pressure in Hypertensive Rats by Downregulating Angiotensin Type 1 Receptor. Front Physiol 2022;13:876777. [DOI: 10.3389/fphys.2022.876777] [Reference Citation Analysis]
35 Mehta J, Kling JM, Manson JE. Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts. Front Endocrinol (Lausanne) 2021;12:564781. [PMID: 33841322 DOI: 10.3389/fendo.2021.564781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Miller VM, Taylor HS, Naftolin F, Manson JE, Gleason CE, Brinton EA, Kling JM, Cedars MI, Dowling NM, Kantarci K, Harman SM. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2021;24:139-45. [PMID: 32880220 DOI: 10.1080/13697137.2020.1804545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]